Hypofractionated spinal stereotactic body radiation therapy for high-grade epidural disease Journal Article


Authors: Rothrock, R. J.; Li, Y.; Lis, E.; Lobaugh, S.; Zhang, Z.; McCann, P.; Santos, P. M. G.; Yang, T. J.; Laufer, I.; Bilsky, M. H.; Schmitt, A.; Yamada, Y.; Higginson, D. S.
Article Title: Hypofractionated spinal stereotactic body radiation therapy for high-grade epidural disease
Abstract: OBJECTIVE: To characterize the clinical outcomes when stereotactic body radiation therapy (SBRT) alone is used to treat high-grade epidural disease without prior surgical decompression, the authors conducted a retrospective cohort study of patients treated at the Memorial Sloan Kettering Cancer Center between 2014 and 2018. The authors report locoregional failure (LRF) for a cohort of 31 cases treated with hypofractionated SBRT alone for grade 2 epidural spinal cord compression (ESCC) with radioresistant primary cancer histology. METHODS: High-grade epidural disease was defined as grade 2 ESCC, which is notable for radiographic deformation of the spinal cord by metastatic disease. Kaplan-Meier survival curves and cumulative incidence functions were generated to examine the survival and incidence experiences of the sample level with respect to overall survival, LRF, and subsequent requirement of vertebral same-level surgery (SLS) due to tumor progression or fracture. Associations with dosimetric analysis were also examined. RESULTS: Twenty-nine patients undergoing 31 episodes of hypofractionated SBRT alone for grade 2 ESCC between 2014 and 2018 were identified. The 1-year and 2-year cumulative incidences of LRF were 10.4% (95% CI 0-21.9) and 22.0% (95% CI 5.5-38.4), respectively. The median survival was 9.81 months (95% CI 8.12-18.54). The 1-year cumulative incidence of SLS was 6.8% (95% CI 0-16.0) and the 2-year incidence of SLS was 14.5% (95% CI 0.6-28.4). All patients who progressed to requiring surgery had index lesions at the thoracic apex (T5-7). CONCLUSIONS: In carefully selected patients, treatment of grade 2 ESCC disease with hypofractionated SBRT alone offers a 1-year cumulative incidence of LRF similar to that in low-grade ESCC and postseparation surgery adjuvant hypofractionated SBRT. Use of SBRT alone has a favorable safety profile and a low cumulative incidence of progressive disease requiring open surgical intervention (14.5%). © AANS 2020, except where prohibited by US copyright law
Keywords: oncology; radiosurgery; spine; stereotactic body radiotherapy; sbrt; spinal
Journal Title: Journal of Neurosurgery: Spine
Volume: 33
Issue: 5
ISSN: 1547-5654
Publisher: American Association of Neurological Surgeons  
Date Published: 2020-11-01
Start Page: 680
End Page: 687
Language: English
DOI: 10.3171/2020.4.Spine20118
PUBMED: 32707555
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 December 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Zhigang Zhang
    427 Zhang
  2. Eric Lis
    138 Lis
  3. Yoshiya Yamada
    479 Yamada
  4. Mark H Bilsky
    319 Bilsky
  5. Patrick Mccann
    13 Mccann
  6. Jonathan T Yang
    166 Yang
  7. Ilya Laufer
    146 Laufer
  8. Adam Michael Schmitt
    50 Schmitt
  9. Patricia Mae Garcia Santos
    46 Santos
  10. Yi Li
    4 Li
  11. Stephanie Marie Lobaugh
    56 Lobaugh